View Author
stent patient strut follow-up month study scaffold lesion vessel 6 months analysis plaque artery trial lumen change implantation group 2 years diameter ultrasound signi baseline result device intravascular everolimu value serruy everolimus-eluting imaging 6- month follow-up coherence tomography table angiographic bioresorbable tissue curvature difference spirit intervention calci tomography angulation procedure reduction intravascular ultrasound segment angiography ficant abbott neointimal vessel wall lumen area scaffold area stenosi figure cardiol target comparison coherence 2 year follow-up calci fied group signi ficantly system outcome bvs 1.0 12 months serruys pw cohort polymer stent thrombosis bioabsorbable process echogenicity assessment stent system image xience 1.0
10 Most Recent Publications
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Gomez-Lara, J. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Rapoza, R. Ormiston, J.A. Serruys, P.W.J.C. Garcia-Garcia, H.M. Heo, J.H. Farooq, V. Geuns, R-J.M. van Chevalier, B. Windecker, S. McClean, D. Thuesen, L. |
2011-11-24
|
|
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Hebert, K.M. Sudhir, K. Garcia-Garcia, H.M. Ormiston, J.A. Dudek, D. Smits, P.C. Koolen, J. Chevalier, B. Bruyne, B. de Thuesen, L. McClean, D. Geuns, R-J.M. van |
2011-10-04
|
|
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography
(Article)
Gomez-Lara, J. Radu, M. Whitbourn, R. Dudek, D. Smits, P.C. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Brugaletta, S. Farooq, V. Diletti, R. Onuma, Y. Windecker, S. Thuesen, L. McClean, D. Koolen, J. |
2011-09-01
|
|
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
(Article)
Diletti, R. Onuma, Y. Chevalier, B. McClean, D. Windecker, S. Whitbourn, R. Smits, P.C. Koolen, J. Meredith, I. Li, D. Veldhof, S. Rapoza, R. Farooq, V. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Gomez-Lara, J. Brugaletta, S. Geuns, R-J.M. van Regar, E.S. Bruyne, B. de Dudek, D. Thuesen, L. |
2011-07-12
|
|
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Smits, P.C. Chevalier, B. Morel, M-A.M. Dorange, C. Veldhof, S. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Farooq, V. Geuns, R-J.M. van Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. Koolen, J. |
2011-07-01
|
|
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Windecker, S. Garcia-Garcia, H.M. Regar, E.S. Serruys, P.W.J.C. Diletti, R. Garg, S.A. Onuma, Y. Gogas, B.D. Geuns, R-J.M. van Dorange, C. Veldhof, S. Rapoza, R. |
2011-02-01
|
|
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial
(Article)
Sarno, G. Bruining, N. Dorange, C. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Onuma, Y. Garg, S.A. Brugaletta, S. Winter, S. de Regar, E.S. Thuesen, L. Dudek, D. Veldhof, S. |
2010-12-01
|
|
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: A pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE v Everolimus Eluting Coronary Stent System [EECSS]
(Article)
Caixeta, A. Lansky, A.J. Sood, P. Su, X. Jonnavithula, L. Sudhir, K. Stone, G.W. Serruys, P.W.J.C. Hermiller, J.B. Ruygrok, P.N. Onuma, Y. Gordon, P. Yaqub, M. Miquel-Hébert, K. Veldhof, S. |
2010-12-01
|
